[HTML][HTML] Copper homeostasis and copper-induced cell death: novel targeting for intervention in the pathogenesis of vascular aging

Z Chen, Y Li, X Liu - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Copper-induced cell death, also known as cuproptosis, is distinct from other types of cell
death such as apoptosis, necrosis, and ferroptosis. It can trigger the accumulation of lethal …

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector

W Lin, Y Yan, Q Huang, D Zheng - Biologics: Targets and Therapy, 2024 - Taylor & Francis
The p53 tumor suppressor protein plays an important role in physiological and pathological
processes. MDM2 and its homolog MDMX are the most important negative regulators of p53 …

Genomic alterations associated with postoperative nodular leptomeningeal disease after resection of brain metastases

RA Morshed, DD Cummins, MP Nguyen, S Saggi… - Journal of …, 2023 - thejns.org
OBJECTIVE The relationship between brain metastasis resection and risk of nodular
leptomeningeal disease (nLMD) is unclear. This study examined genomic alterations found …

Consensus Clustering and Survival‐Related Genes of Cuproptosis in Cutaneous Melanoma

W Qin, F Gan, Y Jike, M Jiang, A Li - Mediators of inflammation, 2023 - Wiley Online Library
As a highly malignant tumor, the morbidity and mortality of cutaneous melanoma (CM) are
increasing year by year. A novel type of cell death connected to mitochondrial metabolism is …

[HTML][HTML] Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities

R Visintin, SK Ray - Cells, 2022 - mdpi.com
Glioblastoma multiforme (GBM) is a brain tumor notorious for its propensity to recur after the
standard treatments of surgical resection, ionizing radiation (IR), and temozolomide (TMZ) …

TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma

SU Khan, Z Ullah, H Shaukat, S Unab… - Cancer …, 2023 - journals.sagepub.com
The present study was the first comprehensive investigation of genetic mutation and
expression levels of the p53 signaling genes in cutaneous melanoma through various …

[HTML][HTML] MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers

J Liu, J Yang, Q Pan, X Wang, X Wang, H Chen… - European Journal of …, 2024 - Springer
MDM4 is one of the MDM protein family and is generally recognized as the key negative
regulator of p53. As a cancer-promoting factor, it plays a non-negligible role in …

CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases

RA Morshed, MP Nguyen, DD Cummins… - Neuro-oncology …, 2023 - academic.oup.com
Background While genetic alterations in brain metastases (BMs) have been previously
explored, there are limited data examining their association with recurrence after surgical …

AutoCancer as an automated multi-modal framework for early cancer detection

L Liu, Y Xiong, Z Zheng, L Huang, J Song, Q Lin… - iScience, 2024 - cell.com
Current studies in early cancer detection based on liquid biopsy data often rely on off-the-
shelf models and face challenges with heterogeneous data, as well as manually designed …

[HTML][HTML] Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status

R Lama, C Xu, SL Galster, J Querol-Garcia… - Frontiers in …, 2022 - frontiersin.org
MDM2 and MDM4 proteins are key negative regulators of tumor suppressor p53. MDM2 and
MDM4 interact via their RING domains and form a heterodimer polyubiquitin E3 ligase …